# FDA 483 - Kerry Inc. - February 21, 2019

Source: https://www.keypedia.com/records/483/kerry-inc/41b0e15c-7542-40af-a0f5-07cf6f0be4ba

> FDA 483 for Kerry Inc. on February 21, 2019. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Kerry Inc.
- Inspection Date: 2019-02-21
- Product Type: other
- Office Name: Dallas District Office
- Summary: An FDA inspection of Kerry Inc. in Fort Worth, TX, a seafood manufacturer, revealed significant deficiencies in its HACCP plan. The firm's plan lacked adequate verification procedures for critical control points, failed to identify Clostridium botulinum as a reasonably likely food safety hazard for certain products, and included an insufficient corrective action plan that did not address regaining control of operations after deviations.

## Related Officers

- [Shannon A Lowe](https://www.keypedia.com/people/shannon-a-lowe/e869cb03-6af7-4483-97b9-74154f6b105f)

Company: https://www.keypedia.com/companies/kerry-inc/bc63c138-de82-4497-95b5-a2c82228bec7

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9